Perineural invasion in intrahepatic cholangiocarcinoma: Meta-analysis of prevalence, association with tumor features, and impact on survival.

JHEP RepJun 25, 2026 (epub)
Clinical ResearchOncology (Medical)GastroenterologyOpen access

Johannes Kolck, Timo Alexander Auer, Camilla Winther Pedersen et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the prevalence and prognostic significance of perineural invasion (PNI) in intrahepatic cholangiocarcinoma (ICC) across 61 studies involving 15,502 patients. The pooled prevalence of PNI was found to be 36.0%. Additionally, PNI was associated with worse overall survival, with a hazard ratio of 1.79.

Key findings

  • The pooled prevalence of PNI in ICC was 36.0% (95% CI 31.0-41.0%).
  • PNI was associated with worse overall survival, with a hazard ratio of 1.79 (95% CI 1.38-2.19).
  • PNI positively correlated with lymph node metastasis, lymphovascular invasion, and vascular invasion (all p <0.001).
  • More recent and larger studies reported lower PNI prevalence.

Why it matters

Understanding the prevalence and implications of PNI in ICC can enhance risk stratification and inform clinical decision-making. This knowledge is crucial for managing patient outcomes and tailoring treatment strategies.

Source

Published in JHEP Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.